Daily Archives: July 12, 2017

Global Probiotics Dietary Supplements Market tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Probiotics Dietary Supplements. This research report offers in-depth analysis of the market size (revenue), market share, major market segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges.

Leading companies operating in the global Probiotics Dietary Supplements market profiled in the report are NutraScience Labs, Vitakem Nutraceuticals Inc., ProbioFerm, UAS Labs, Probium LLC, Protexin, Nutraceutix, Chr. Hansen Holding A/S, Nebraska Cultures, Mercola Probiotics, Contract NUTRA, UP4 Probiotics, Custom Probiotics, Inc.

This report segments the global Probiotics Dietary Supplements market on the basis of types, Baby Use, Adult Use, Other. On the basis of application, the global Probiotics Dietary Supplements market is segmented into Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula. For comprehensive understanding of market dynamics, the global Probiotics Dietary Supplements market is analyzed across key geographies namely North America, China, Europe, Southeast Asia, Japan, India. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Inquire for sample at :

https://www.marketinsightsreports.com/reports/071214791/global-probiotics-dietary-supplements-market-professional-survey-report-2017/inquiry

15 Chapters to deeply display the global Probiotics Dietary Supplements market.

Chapter 1, to describe Probiotics Dietary Supplements Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Probiotics Dietary Supplements, with sales, revenue, and price of Probiotics Dietary Supplements, in 2016and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Probiotics Dietary Supplements, for each region, from 2012to 2017;

Chapter 5, 6, 7,8and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Probiotics Dietary Supplements market forecast, by regions, type and application, with sales and revenue, from 2017to 2022;

Chapter 13, 14 and 15, to describe Probiotics Dietary Supplements sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Browse Full Report at :

https://www.marketinsightsreports.com/reports/071214791/global-probiotics-dietary-supplements-market-professional-survey-report-2017

This report provides in-depth analysis of the Probiotics Dietary Supplements and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 2022, considering 2016 as the base year. It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. This study also provides key insights about market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading players. It profiles leading players in the global Probiotics Dietary Supplements market based on the following parameters company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans Key companies covered as a part of this study include. Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, market expansion, and marketing tactics. The global Probiotics Dietary Supplements market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for Probiotics Dietary Supplements equipment, government organizations, research and consulting firms, new entrants, and financial analysts. Various strategy matrices used in analyzing the Probiotics Dietary Supplements market would provide stakeholders vital inputs to make strategic decisions accordingly.

The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.

Link:

Probiotics Dietary Supplements Market Analysis & Trends 2017 - Equity Insider (press release)

In the United States, dietary supplements and their ingredients are subject to a patchwork of regulations, industry guidance, voluntary certifications and audit programs. With some exceptions, few standards have been developed with expert consensus and then broadly implemented by the dietary supplement industry. FDAs dietary supplement GMPs (good manufacturing practices) are part of the exception and have made todays supplement products generally a higher level of quality than at any time before.

Yet, few industry standards are clearly understood, consistently applied and sufficiently comprehensive to cover all the ground. One primary example is the gap between compliance requirements for dietary ingredients (under food GMPs) and dietary supplements, whose GMP framework is derived from that for pharmaceuticals. The underlying litmus test for the level of safety demanded for supplements and foods are differentthat of non-adulteration" versus safe for human consumption," Respectively. Maybe due to the differences, supplement GMP audit programs can overlook the food GMPs that govern ingredients. It is not uncommon for a manufacturer and a supplier to speak completely different quality languages. Audits for supplement GMPs are frequently unable to determine to a reasonable degree of certainty whether a particular ingredient, based on its certificate of analysis (CoA), should be expected to meet supplement requirements once it is placed inside a capsule or tablet.

As could be expected, an unintended consequence of this gap is the common practice of a raw material CoA being duplicated as the manufacturers raw material specification. In this scenario, an ingredient specification has been developed according to food requirements and, often without further analysis or verification, it is assumed to meet the requirements of the finished supplement. The result is a supplement that is essentially of no better quality than the food-grade" ingredients put into it.

For botanicals and animal-derived raw materials, cultivation, harvesting and processing before they are made into usable ingredients adds another dimension. This is a complicated problem, particularly for a global supply chain of agricultural materials susceptible to contaminants during farming, harvesting, processing, storage or transportation to the ingredient processing facility. These contaminants may not be necessarily listed on the specification or controlled by the food GMPs, yet they can cause the supplements to which they are added to be adulterated.

Dozens of standards have been written for agricultural products, many of which dont (or cant) apply to the small family farmers who are a predominant source of botanical raw materials. In addition to recent requirements for fresh produce established by the Food Safety Modernization Act (FSMA), which dont really apply to dried agricultural materials, we also have: USDA good agricultural practices (GAPs), which are intended for large farms and seldom fully practiced in the United States; certified organic, which requires no testing for contaminants like pesticides that may cause a product to be adulterated; independent farm standards like Global GAP, which arealso intended for large, modernized industrial farms; and, dozens of good agricultural and collection practices (GACPs) for medicinal plants that have been independently written by various nations and trade groups.

Some experts say the mess of standards, the dynamics of the industry and the law of entropy do not support the possibility of a clear and unified regulatory structure. Others recognize the limitations, yet remain busy sewing the patches together into a quilt that is greater than the sum of its parts.

Fortunately, initiatives are in process or recently completed that contribute to the integrity of our industry quilt and have provided free information. Just in the past couple years:

The U.S. Pharmacopoeia (USP) and American Herbal Pharmacopoeia (AHP) developed monographs and methods for testing dietary supplement ingredients.

USP also developed a Food Fraud Mitigation Database that lists adulterants common for food ingredients.

AOAC International developed analytical methods for dietary supplement ingredient potency and contaminants.

The National Institutes of Healths (NIH) Office of Dietary Supplements (ODS) website became a valuable source of information and resources.

Trade groups such as the American Herbal Products Association (AHPA) and American Botanical Council (ABC) made enormous efforts to educate and guide the industry on issues around botanical dietary ingredients and adulteration, including a recently updated draft GACP from AHPA, and the ABC-AHP-National Center for Natural Products Research (NCNPR) Botanical Adulterants Program.

The Supplement Online Wellness Library (OWL) was established by the Council for Responsible Nutrition (CRN), to allow labels for supplement products on the U.S. market to be put into in one place.

The Supplement Safety and Compliance Initiative (SSCI) was formed as a broad industry initiative, with wide support from trade associations, to address some of the gaps for supplements that arent sufficiently covered under other standards. SSCI is led by experienced players in retail, manufacturing and supply, and includes a focus on identity, risk assessment and quality for raw materials.

In response to consumer demand, leading retailers, manufacturers and ingredient suppliers invested significant resources into traceability and quality, and are now able to make meaningful claims to these effects that are not only important to consumers, but also serve as a reliable way to differentiate from the competition.

Todays movement toward a greater level of education and transparency includes a firming of the gaps, especially where raw material traceability and quality are concerned. Successful companies across the entire supply chain are actively improving and adopting new standards, building a level of quality and integrity that provides lasting value to their business. Those who are upping their game are piecing together a quilt of their own, leveraging their quality advantages into claims that deliver marketing value. On the other side, those who continue to rely on ignorance or a lack of regulatory clarity as reason to take no action are increasingly left behind.

In an industry where faceless online product marketers are more common than they should be, and where a list of the tens of thousands of products on the market is just getting kicked off, efforts to fill in the gaps of our patchwork are a good thing for everyone.

Blake Ebersole has led a number of botanical quality initiatives and formed collaborations with dozens of universities and research centers. As president of NaturPro Scientific, Ebersole established quality compliance and product development services for supplements and ingredients such as ID Verified. Follow him on Twitter at @NaturalBlake.

Continued here:

Making A Quilt from the Regulatory Patchwork - Natural Products INSIDER

Press Release

The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, today announced it is exploring adding representation for companies in the medical food industry to its mission, following a unanimous vote by the CRN Board of Directors at its June Board meeting to launch an examination of this burgeoning sector of the nutrition category.

According to CRN Board Chair Jim Hyde, vice president & general manager, Balchem Human Nutrition and Pharma, CRNs Board of Directors believes there is enormous growth potential for the medical food industry over the next several decades as healthcare practitioners, the academic community, and policy makers continue to look at the ways that nutrition contributes to better health. We take seriously the name of our association, and incorporating medical food along with dietary supplements and functional food to our responsible nutrition portfolio is forward-thinking and a logical next step for CRN to consider.

CRN President & CEO Steve Mister focused on the potential synergy of adding medical food, explaining, "CRN's strong reputation was created by our forty-five year history of representing mainstream companies in the dietary supplement industry. Several years ago, we opened our doors to functional food companies with the reasoning that we were already representing the ingredient suppliers manufacturing the ingredients that went into the food. We envision the same synergistic approach with medical food. It's all a spectrum of nutrition that provides health benefits to consumers. If there is an interest from companies who manufacture and market medical foods, we're open to working with those companies to ensure their interests-and the interests of their consumers-are being properly represented to Congress, regulators, and in the media."

As part of its exploratory process, CRN intends to convene the major players in the industry, some of whom are already CRN members, as part of a listening tour to determine where voids in representation exist, if CRN can fill those needs, and what the regulatory and policy priorities of the medical food industry should be. Weve already begun talking with some of the significant providers of these products to the market, and we understand some of their concerns focus on the lack of clarity provided by FDAs oversight of the industry, leading to some controversy and uncertainty about these products, said Mr. Mister.

The term medical food is defined by Congress under Section 5(b)(3) of the Orphan Drug Act as a food which is formulated to be consumed [orally] or administered internally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.

CRN has previously expressed concerns that a more narrow interpretation of that definition offered by FDA that limits the range of available products may undermine Congressional intent for this category, thereby stifling the markets ability to reach its potential. On the other hand, CRN fears that some companies may try to take advantage of the lack of clarity with illegitimate products, leaving the industry open to the risk that rogue players will define the industry.

"In many ways, there are similarities between where medical foods are today and the dietary supplement industry immediately following the passage of the Dietary Supplement Health and Education Act," said Mr. Mister. "CRN wants to work with responsible companies who want to play by the rules. We want to ensure those rules protect consumers, but also allow for industry to innovate and grow. Twenty years from now, we don't want medical food companies to be in the position of looking back and wishing they had established themselves as a unified industry sooner. Consumers will benefit from a vibrant medical food industry that develops and delivers helpful, innovative products under reasonable regulation that assure fly-by-night companies don't grab and destroy the reputation of those companies investing in science and following the law."

Read more:

CRN to Explore Adding Medical Food to its Mission - Natural Products INSIDER